O'Shaughnessy Asset Management, LLC United Therapeutics Corp Transaction History

O'Shaughnessy Asset Management, LLC

$8.9 Billion
Q1 2024

A detailed history of O'Shaughnessy Asset Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 2,218 shares of UTHR stock, worth $703,216. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,218

Previous 2,451 9.51%

Holding current value

$703,216

Previous $538,000 5.39%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$210.76 - $249.51 $49,107 - $58,135	-233 Reduced 9.51%	2,218 $509,000
Q4 2023 Feb 09, 2024	BUY	$214.88 - $256.94 $32,446 - $38,797	151 Added 6.57%	2,451 $538,000
Q3 2023 Nov 13, 2023	BUY	$211.82 - $248.24 $22,664 - $26,561	107 Added 4.88%	2,300 $519,000
Q2 2023 Aug 11, 2023	SELL	$205.19 - $232.99 $11,080 - $12,581	-54 Reduced 2.4%	2,193 $484,000
Q1 2023 May 12, 2023	SELL	$212.99 - $276.17 $106,920 - $138,637	-502 Reduced 18.26%	2,247 $503,000

Q4 2022 Feb 10, 2023	SELL	$205.95 - $280.43 $13,592 - $18,508	-66 Reduced 2.34%	2,749 $764,000
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $7,318 - $8,790	-36 Reduced 1.26%	2,815 $589,000
Q2 2022 Aug 11, 2022	SELL	$174.81 - $241.14 $21,676 - $29,901	-124 Reduced 4.17%	2,851 $672,000
Q1 2022 May 13, 2022	SELL	$166.16 - $213.96 $360,401 - $464,079	-2,169 Reduced 42.17%	2,975 $534,000
Q4 2021 Feb 11, 2022	SELL	$184.32 - $216.08 $29,859 - $35,004	-162 Reduced 3.05%	5,144 $1.11 Million
Q3 2021 Nov 10, 2021	BUY	$179.86 - $214.88 $128,240 - $153,209	713 Added 15.52%	5,306 $979,000
Q2 2021 Aug 09, 2021	BUY	$170.47 - $211.93 $67,847 - $84,348	398 Added 9.49%	4,593 $824,000
Q1 2021 May 14, 2021	BUY	$153.94 - $174.85 $165,023 - $187,439	1,072 Added 34.33%	4,195 $702,000
Q4 2020 Feb 11, 2021	SELL	$101.87 - $151.79 $384,661 - $573,159	-3,776 Reduced 54.73%	3,123 $474,000
Q3 2020 Nov 12, 2020	BUY	$99.9 - $121.13 $542,956 - $658,341	5,435 Added 371.24%	6,899 $698,000
Q2 2020 Aug 13, 2020	BUY	$92.74 - $125.82 $135,771 - $184,200	1,464 New	1,464 $177,000
Q1 2020 May 13, 2020	SELL	$79.39 - $115.35 $46,204 - $67,133	-582 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$78.31 - $95.34 $45,576 - $55,487	582 New	582 $51,000
Q4 2018 Feb 12, 2019	SELL	$101.4 - $128.73 $709 - $901	-7 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$113.81 - $129.46 $227 - $258	-2 Reduced 22.22%	7 $1,000
Q1 2018 May 08, 2018	SELL	$107.21 - $151.94 $64,433 - $91,315	-601 Reduced 98.52%	9 $1,000
Q4 2017 Feb 13, 2018	SELL	$118.58 - $151.28 $2.39 Million - $3.05 Million	-20,174 Reduced 97.07%	610 $90,000
Q3 2017 Nov 13, 2017	SELL	$114.6 - $136.81 $60,394 - $72,098	-527 Reduced 2.47%	20,784 $2.44 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,311	21,311 $2.77 Million

Others Institutions Holding UTHR

# of Institutions

561

Shares Held

43.1M

Call Options Held

501K

Put Options Held

529K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.

Account

O'Shaughnessy Asset Management, LLC United Therapeutics Corp Transaction History